Pregnancy: The safety of Meronem IV in human pregnancy has not been evaluated. Animal studies have not shown any adverse effect on the developing foetus. The only adverse effect observed in animal reproductive studies was an increased incidence of abortions in monkeys at 13 times the expected exposure in man. Meronem IV should not be used in pregnancy unless the potential benefit justifies the potential risk to the foetus. In every case, it should be used under the direct supervision of the physician.
Lactation: Meropenem has been reported to be excreted in human milk. Meronem IV should not be used in breast-feeding women unless the potential benefit justifies the potential risk to the baby.